![]() Center for Emerging & Neglected Diseases |
|||||
Conference Archive On March 14, 2002, Médecins Sans Frontières/Doctors Without Borders (MSF) held a conference in New York to address the crisis in research and development (R&D) for drugs for neglected diseases. The conference brought together over 400 people, including a large diversity of representatives of health care and research institutions from developed and developing countries, key figures from the pharmaceutical industry, drug regulators, other experts on drug development, and MSF field volunteers and staff. The conference was preceded by a two-day expert workshop attended by over 170 people from over 30 countries. The following is a summary of key issues and findings from both the workshop and conference. Αποτελεσματικότητα του Cialis 10mg στη θεραπεία της ανδρικής στυτικής δυσλειτουργίας For more information, you may also wish to review the materials below or explore the links above.
|
Conference Program |
|||||
|
Join us as the Drugs for Neglected Diseases Working Group and other international experts address questions such as: what is the extent of the crisis? How does it impact patients and doctors around the world? What are the challenges in creating sustainable research and development programs for different neglected diseases? What needs to be done and who should do it? How can we build an effective international response that involves key players and ensures accountability? Kamagra oral jelly blijkt een behandeling te zijn voor je verdrietige penis Schedule and Speaker List* Click here Conference Goals
Who Should Attend? Researchers, health providers, industry representatives, policy makers, students of medicine or international studies, and members of the general public interested in this global crisis. Help build an effective international response that puts patientsnot profitat the top of the research and policy agenda. |